RAQUALIA PHARMA INCRAQUALIA PHARMA INCRAQUALIA PHARMA INC

RAQUALIA PHARMA INC

No trades
See on Supercharts

4579 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. Its medicines focus on pain, gastrointestinal, auto-immune diseases, inflammation, cancer, and Alzheimer's. Its products include Anidulafungin, Dalbavancin, Ziprasidone, 5-HT4 Partial Agonist, and 5-HT2B Antagonist. The company was founded on February 19, 2008 and is headquartered in Nagoya, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
4579 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company